Cure My Disease

Don't miss your cure!

Log in / Sign up

← Back to home

Hansoh Biomedical R&d Company

Clinical trials sponsored by Hansoh Biomedical R&d Company, explained in plain language.

Now part of Jiangsu Hansoh Pharmaceutical Group Co., Ltd. 3692 HKEX

Research and development arm of a major Chinese pharmaceutical company.

Not investment advice. Company information is shown for context only. Clinical trials frequently fail.

Trials to join now! 9 Not yet recruiting 2 Not yet finished but already full! 1 Completed 1

New hope for tough bone cancer: experimental drug takes on chemo in Late-Stage trial

Disease control Ongoing

This study tests an experimental drug called HS-20093 against a standard chemotherapy combination (gemcitabine plus docetaxel) in people with osteosarcoma (a type of bone cancer) that has not responded to at least two prior treatments. About 117 participants aged 12 and older wil…

Phase: PHASE3 • Sponsor: Hansoh BioMedical R&D Company • Aim: Disease control

Last updated Jun 27, 2026 12:05 UTC